Professor, Medicine, University of Alabama School of Medicine
Infectious Disease
Dr. Peter G. Pappas, MD
|
|
Give Review
Peter Pappas works in the field of Infectious Disease. He went to University of Alabama School of Medicine. University of Alabama School of Medicine is ranked 37/17 in Research/PrimaryCare. He has 1 awards "Top MD". Peter G. Pappas, MD is a published MD. He has 66 papers published. The most current publication "Cryptococcal osteomyelitis: a report of 5 cases and a review of the recent literature." He accepts all Medicare patients.
Publications
- Invasive Candidiasis.
- T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.
- Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole versus Amphotericin B for Therapy of Invasive Aspergillosis. A Col...
- Reversible blindness in cryptococcal meningitis with normal intracranial pressure: case report and review of the literature.
- Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).
- MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in ...
- Lessons learned in the multistate fungal infection outbreak in the United States.
- Target lesions in a neutropenic patient.
- Immunosuppression Regimen and the Risk of Acute Rejection in HIV-Infected Kidney Transplant Recipients.
- Cryptococcal Infections: Changing Epidemiology and Implications for Therapy.
- Real-time Treatment Guidelines: Considerations During the Exserohilum rostratum Outbreak in the United States.
- Prototheca wickerhamii algaemia presenting as cholestatic hepatitis in a patient with systemic lupus erythematosus: A case report and literature review.
- Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-un...
- Fatal Burkholderia gladioli infection misidentified as Empedobacter brevis in a lung transplant recipient with cystic fibrosis.
- Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
- Safety and Tolerability of Voriconazole in Patients with Baseline Renal Insufficiency and Candidemia.
- Pulmonary cryptococcosis.
- Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
- Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of fact...
- Ocular manifestations of candidemia.
- Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease.
- In vitro susceptibility of Aspergillus to echinocandins: Isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.
- A comparison of in vitro susceptibility of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: TRANSNET 2001-2006.
- Opportunistic fungi: a view to the future.
- Cryptococcal meningitis: current approaches to management in patients with and without AIDS.
- Factors associated with mortality in transplant patients with invasive aspergillosis.
- Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
- Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Su...
- Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era.
- Cryptococcosis in the developing world: an elephant in the parlor.
- Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
- Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network.
- Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.
- Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
- A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis.
- Blastomycosis: new insights into diagnosis, prevention, and treatment.
- Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.
- Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
- Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy.
- Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatme...
- Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis .
- Combination antifungal therapy for the treatment of invasive yeast and mold infections.
- Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
- Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods.
- Design and methodology of the Strategies to Reduce Transmission of Antimicrobial Resistant Bacteria in Intensive Care Units (STAR-ICU) trial.
- Invasive candidiasis in the intensive care unit.
- Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
- Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supporte...
- Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.
- Managing cryptococcal meningitis is about handling the pressure.
- Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient.
- Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.
- Epidemiology of Aspergillus terreus at a university hospital.
- Donor-related coccidioidomycosis in organ transplant recipients.
- Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.
- Current Concepts in the Management of Fungal Peritonitis.
- Blastomycosis: Gilchrist's disease revisited.
- Therapy of Cryptococcal Meningitis in non-HIV-infected Patients.
- Antifungal Clinical Trials and Guidelines: What We Know and Do Not Know.
- Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis:...
- Cryptococcal infections in non-hiv-infected patients.
- Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status.
- Cryptococcal osteomyelitis: a report of 5 cases and a review of the recent literature.
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
- Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.
Schools
University Of Alabama School Of Medicine
University of Washington
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Top MD
Education
-
University of Washington -
University of Alabama School of Medicine
Hospital
-
University of Alabama Hospital -
Birmingham Veterans Affairs Medical Center -
Cooper Green Hospital
Drug Facts
| NPI NUMBER | 1811921497 | |
| NPPES Provider LastName | PAPPAS | |
| NPPES Provider FirstName | PETER | |
| NPPES Provider ZIPCode | 35233 | |
| NPPES Provider State | AL | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 78.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811921497 |
| Last Name Of The Provider | PAPPAS |
| First Name Of The Provider | PETER |
| View All |
Similar Doctors
|
|
Dr. Michael S. Saag, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John W. Baddley, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. William E. Dismukes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica S. Merlin, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ricardo A. Franco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Gnann Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane R. Schwebke, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Bruce A. Tucker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis G. Delgado, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony P. Cannella, MD |
|
|
Dr. David O. Freedman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Stephen J. Jordan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Kilby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mukesh Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meryl A. Twarog, MD |
|
|
Dr. Hisham Ibrahim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. McCollum, MD
This Doctor is OpenDoctor Recommended.
|